Core Viewpoint - Under debt pressure, New World Development, one of Hong Kong's "four major families" in real estate, is seeking potential investors, with Blackstone Group reportedly in talks to become the largest shareholder, potentially leading to a loss of control for the founding Cheng family [1][2]. Group 1: Company Situation - New World Development has confirmed that its controlling shareholder, Chow Tai Fook Enterprises, is in discussions with multiple potential investors, although no agreements have been reached yet [1]. - The company has faced significant debt pressure, with total debt amounting to HKD 1,460 billion and net debt at HKD 1,201 billion, making it one of the highly leveraged real estate firms in Hong Kong [3][4]. - The company is focusing on debt reduction, having sold various assets, including stakes in the Kai Tak Sports Park and landmark projects in Beijing and Shanghai, resulting in a decrease of total debt by HKD 5.7 billion year-on-year [3]. Group 2: Market Context - The Hong Kong residential market is showing signs of recovery after three years of stagnation, with private residential prices expected to rise by 3.3% in 2025, and predictions of a further increase of 5% to 10% in 2026 [5]. - New World Development holds substantial land reserves, with 3.38 million square feet of property development area in Hong Kong and 2.92 million square meters of land reserves in mainland China, which could serve as leverage in negotiations with potential investors [4][5]. - The interest from Blackstone Group is seen as a positive signal by the market, reflecting confidence in the long-term value of New World Development's assets [2].

Group 1 - The core viewpoint of the article is that Sai Sheng Pharmaceutical's K11 project has entered the Phase III clinical trial stage, with over 70 research centers initiated for the trial [2] - The company has stated that it expects to complete all patient enrollment by the end of the year, indicating that the project is progressing normally [2]